Overview

Detailed Summary

Tejnaksh Healthcare Limited specializes in urology services, providing comprehensive healthcare solutions through its Institute of Urology in Dhule, Maharashtra.
The company transformed from a private to a public entity in 2015, expanding its service offerings and geographic presence in Maharashtra and Madhya Pradesh.
Tejnaksh Healthcare prides itself on pioneering initiatives such as North Maharashtra’s first Urodynamics Lab and indigenous PCNL simulation labs.
The company's efforts focus on strengthening healthcare in rural India, offering affordable and quality healthcare services with multiple urology clinics and hospitals.

Sector: Healthcare Services
Industry: Healthcare Service Provider
Market Cap: 32 Cr
Volatility: Low Risk
P/E Ratio: 24.9
Industry P/E: 56.0
PEG Ratio: 18.6
P/B Ratio: 1.2
52W High: 24.29
52W Low: 10.65

Sales CAGR

1Y: 5.91%
3Y: 2.72%
5Y: -5.21%
10Y: 7.10%

Profit CAGR

1Y: 26.70%
3Y: 1.34%
5Y: 6.39%
10Y: 7.91%

ROE

TTM: 6.34%
3Y: 8.41%
5Y: 9.78%
10Y: 12.88%

ROCE

TTM: 9.29%
3Y: 11.38%
5Y: 12.39%
10Y: 15.71%

Technicals

‌

Forecasts

Peers

Healthcare Healthcare Healthcare Services Healthcare Service Provider

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
SAMSRITA		17.08	37 Cr	-5.17	2.43	0.00	-29.86	-30.51	-47.38
SHARMEH		101.95	35 Cr	28.32	2.83	0.00	9.84	10.99	3.78
TEJNAKSH		15.44	32 Cr	24.90	1.19	0.00	6.34	9.29	4.08
CMMHOSP		35.75	29 Cr	-32.80	0.00	0.00	35.31	-0.76	-3.69
DECCAN		8.25	28 Cr	8.42	0.25	0.00	1.30	1.99	1.64
NIDAN		13.90	22 Cr	9.79	0.32	0.00	3.32	6.57	2.69
TRABI		2.22	22 Cr	-8.88	2.35	0.00	-17.64	-3.52	-1.32
Median: 7 Co.	—	15.44	29 Cr	8.42	1.19	0.00	3.32	1.99	1.64

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	3.09	3.14	2.92	3.12	3.37	3.19	3.21	2.64	2.98	2.62
Expenses	1.96	2.07	2.01	2.05	2.21	2.06	2.51	2.04	2.20	1.93
Operating Profit	1.13	1.07	0.91	1.07	1.16	1.13	0.70	0.60	0.78	0.69
OPM %	36.57	34.08	31.16	34.29	34.42	35.42	21.81	22.73	26.17	26.34
Other Income	0.08	0.07	0.07	0.07	0.09	0.17	0.07	0.09	0.09	0.07
Interest	0.16	0.19	0.14	0.12	0.11	0.14	0.01	0.05	0.03	0.04
Depreciation	0.23	0.23	0.23	0.23	0.31	0.20	0.17	0.36	0.35	0.36
Profit Before Tax	0.83	0.72	0.61	0.80	0.83	0.97	0.59	0.29	0.49	0.36
Tax %	26.51	25.00	26.23	25.00	21.69	42.27	28.81	24.14	30.61	19.44
Net Profit	0.61	0.54	0.46	0.60	0.65	0.56	0.42	0.21	0.33	0.29
EPS in Rs	0.28	0.27	0.25	0.29	0.31	0.38	0.21	0.12	0.15	0.14

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	7.28	14	20	17	12	13	12	12	13	12
Expenses	4.09	8.80	16	13	8.25	7.92	8.04	8.56	8.82	8.82
Operating Profit	3.19	5.34	4.18	4.04	3.71	4.75	3.69	3.62	4.07	3.59
OPM %	43.83	37.75	21.16	23.60	31.04	37.50	31.44	29.72	31.58	28.93
Other Income	0.19	0.39	1.55	0.34	0.14	0.15	0.31	0.31	0.40	0.42
Interest	0.19	0.98	0.78	0.76	0.50	0.47	0.61	0.64	0.38	0.31
Depreciation	0.35	0.47	0.59	0.65	0.68	0.67	0.87	0.91	0.91	1.04
Profit Before Tax	2.84	4.28	4.36	2.97	2.67	3.76	2.51	2.38	3.19	2.68
Tax %	32.84	25.64	28.12	27.65	22.44	25.25	28.70	25.73	30.11	31.34
Net Profit	1.91	3.18	3.14	2.15	2.07	2.81	1.79	1.76	2.23	1.84
EPS in Rs	—	—	—	1.04	1.01	1.34	0.84	0.84	1.19	0.62
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	1.10	2.21	2.21	10	10	10	10	10	10	10
Reserves	5.14	5.86	7.93	3.00	5.09	7.16	9.90	12	13	16
Borrowings	0.00	6.39	7.35	5.95	6.59	4.19	6.31	5.91	4.13	0.63
Other Liabilities	0.60	1.07	2.28	3.15	3.06	3.07	3.24	3.55	3.66	3.77
Total Liabilities	6.84	16	20	22	25	25	30	31	31	30
Fixed Assets	3.34	14	15	17	17	15	15	23	23	21
CWIP	0.00	0.00	0.00	0.39	0.65	0.79	8.89	0.95	1.07	1.33
Investments	2.59	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	0.91	1.91	4.44	4.90	6.89	8.74	5.33	6.86	7.06	7.81
Total Assets	6.84	16	20	22	25	25	30	31	31	30

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	3.67	2.25	4.49	3.15	1.16	1.18	9.21	2.12	4.21	—
Cash from Investing Activity	-3.26	-8.03	-3.24	-1.55	-1.21	1.56	-11	-1.40	-1.22	0.00
Cash from Financing Activity	-0.13	6.43	-0.66	-2.09	0.10	-2.80	1.62	-1.20	-2.27	—
Net Cash Flow	0.29	0.65	0.59	-0.50	0.05	-0.06	0.24	-0.48	0.73	0.00

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoters	73.83%	73.83%	73.83%	73.83%	73.83%	73.83%	73.83%	73.83%	73.83%	73.83%	73.83%	73.83%
FIIs	0.58%	0.58%	0.58%	0.58%	0.28%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	25.59%	25.59%	25.59%	25.59%	25.89%	26.17%	26.17%	26.17%	26.17%	26.17%	26.17%	26.17%
Total Shareholders	1,445	1,636	2,628	3,057	3,502	3,776	4,067	4,496	4,493	4,552	4,550	4,452

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q3 FY18

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Frequently Asked Questions about Tejnaksh Healthcare Ltd

Tejnaksh Healthcare Ltd (TEJNAKSH) is currently trading at 15.90 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Tejnaksh Healthcare Limited specializes in urology services, providing comprehensive healthcare solutions through its Institute of Urology in Dhule, Maharashtra. The company transformed from a private to a public entity in 2015, expanding its service offerings and geographic presence in Maharashtra and Madhya Pradesh. Tejnaksh Healthcare prides itself on pioneering initiatives such as North Maharashtra’s first Urodynamics Lab and indigenous PCNL simulation labs. The company's efforts focus on strengthening healthcare in rural India, offering affordable and quality healthcare services with multiple urology clinics and hospitals.

Over the past 52 weeks, Tejnaksh Healthcare Ltd has traded between a low of ₹10.65 and a high of ₹24.29. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Tejnaksh Healthcare Ltd has a market capitalization of approximately 31.51. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Tejnaksh Healthcare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 24.90 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 31.51 Cr, Tejnaksh Healthcare Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Tejnaksh Healthcare Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Tejnaksh Healthcare Ltd is 24.90. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Tejnaksh Healthcare Ltd

Stock Summary and Key Metrics

Investment Checklist

Investment Checklist

Overview

Financial Ratios

Technicals

Forecasts

Peers

Price Chart Comparison

Financial Statements

AI Powered Summary

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

Consolidated Profit Loss (in ₹ Crores)

Consolidated Balance Sheet (in ₹ Crores)

Consolidated Cash Flows (in ₹ Crores)

Shareholdings

Shareholding History

Market Transactions

Unlock more with professional

Projection

Documents

Actions

Announcements

AI Mode

Ask AI

Frequently Asked Questions about Tejnaksh Healthcare Ltd

What is Tejnaksh Healthcare Ltd share price today?

What does Tejnaksh Healthcare Ltd do?

What is the 52-week high and low of Tejnaksh Healthcare Ltd?

What is the market capitalization of Tejnaksh Healthcare Ltd?

Should I consider investing in Tejnaksh Healthcare Ltd stock?

Is Tejnaksh Healthcare Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Tejnaksh Healthcare Ltd belong to and why does it matter?

What is the PE ratio of Tejnaksh Healthcare Ltd?

Investor’s Suite

Market Explorer

Market Pulse

Deep Dive

Utility

Company

Technicals

Forecasts

Projection

Frequently Asked Questions about Tejnaksh Healthcare Ltd

What is Tejnaksh Healthcare Ltd share price today?

What does Tejnaksh Healthcare Ltd do?

What is the 52-week high and low of Tejnaksh Healthcare Ltd?

What is the market capitalization of Tejnaksh Healthcare Ltd?

Should I consider investing in Tejnaksh Healthcare Ltd stock?

Is Tejnaksh Healthcare Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Tejnaksh Healthcare Ltd belong to and why does it matter?

What is the PE ratio of Tejnaksh Healthcare Ltd?

Oscillators

Neutral

Overall

Bullish

Moving Averages

Bullish

Overall

Bullish

Peers

Price Chart Comparison

Announcements

Overview

Financial Ratios

Investment Checklist